share_log

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

派珀·桑德勒维持对Merit Medical Systems的增持,将目标股价上调至95美元
Benzinga ·  01/12 10:52

Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $88 to $95.

派珀·桑德勒分析师杰森·贝德纳维持Merit Medical Systems(纳斯达克股票代码:MMSI)的增持,并将目标股价从88美元上调至95美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发